WeVote
Log In

Bill

Bill

SR 22

Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

2026-2027 Regular Session

New Jersey resolution urges Supreme Court to protect access to abortion medication mifepristone and reproductive choice rights.

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
0
WeVote Research Nonpartisan
Bill Summary · SR 22

Legislative bill overview

SR 22 is a New Jersey state resolution that urges the U.S. Supreme Court to protect access to mifepristone (an abortion medication) and reproductive choice. As a resolution rather than a law, it is non-binding and serves as a statement of legislative intent rather than creating enforceable policy.

Why is this important

Mifepristone remains at the center of national abortion access debates following FDA approval challenges and legal disputes. This resolution signals New Jersey's official position on medication abortion access and may influence state-level regulatory decisions or support litigation efforts that align with the resolution's stance.

Potential points of contention

  • Judicial overreach concerns: Opponents argue state resolutions urging the Supreme Court on pending cases constitute inappropriate legislative pressure on the judiciary
  • Abortion policy disagreement: Those opposed to medication abortion access view this as advocacy for a policy outcome they fundamentally oppose on moral or safety grounds
  • Non-binding nature: Critics may question whether symbolic resolutions represent an efficient use of legislative time compared to direct policy action

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.